Search

1 to 10 of 27
Sort by


Event
SITC Cancer Immunotherapy Guidelines – Squamous Cell Carcinoma of the Head and Neck (HNSCC) Webinar

On July 24, 2019, leading experts in cancer immunotherapy presented an overview of the recently published SITC Cancer Immunotherapy Guidelines – Squamous Cell Carcinoma of the Head and Neck (HNSCC) at a live webinar. This FREE CME-, CNE-, CPE-certified webinar provided a chance for...

 07-24-2019 | 15:00 - 16:00 ET


Web Page
Immune-Related Adverse Events

SITC Cancer Immunotherapy Guidelines (CIGs) are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key clinical recommendations to help practicing oncologists determine when and how to best use immunotherapy...


Web Page
Lymphoma

SITC Cancer Immunotherapy Guidelines (CIGs) are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their...


Web Page
Multiple Myeloma

SITC Cancer Immunotherapy Guidelines (CIGs) are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their...



Library Entry
SITC Cancer Immunotherapy Guidelines - Non-small Cell Lung Cancer (NSCLC) Recorded Webinar

On September 13, 2018, leading experts in cancer immunotherapy presented an overview of the recently updated SITC Cancer Immunotherapy Guidelines - Non-small Cell Lung Cancer (NSCLC) at a live webinar. The webinar faculty presented and discussed: The role of immunotherapy for the treatment...


Library Entry
SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma Webinar - Webinar and Presentation Slides

On July 30, 2018, leading experts in cancer immunotherapy presented an overview of the publication "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of cutaneous melanoma: version 2.0" at a live webinar. The recorded webinar and presentation slides...

2 attachments


Library Entry
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy – characterized by some benefit but only rare durable responses – was the only treatment option for patients with...